Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-25 Sale |
2022-05-26 4:05 pm |
POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer |
564,204 | $7.51 | $4,237,172 | 3,256,574 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-02 Option Award |
2022-06-06 4:04 pm |
N/A 2028-06-02 |
POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director |
25,614 | $0 | 25,614 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:03 pm |
N/A 2028-06-02 |
POINT Biopharma Global Inc. | PNT | Malik Rajesh Director |
25,614 | $0 | 25,614 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 10:48 am |
N/A 2028-04-01 |
POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development |
13,766 | $0 | 13,766 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 5:01 pm |
N/A 2028-03-29 |
POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development |
213,301 | $0 | 213,301 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 5:00 pm |
N/A 2028-03-29 |
POINT Biopharma Global Inc. | PNT | KELLY JUSTYNA Chief Operating Officer |
77,958 | $0 | 77,958 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 5:00 pm |
N/A 2028-03-29 |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman 10% Owner |
332,476 | $0 | 332,476 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 4:58 pm |
N/A 2028-03-29 |
POINT Biopharma Global Inc. | PNT | DEMERS WILLIAM L. Chief Financial Officer |
105,360 | $0 | 105,360 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 4:57 pm |
N/A 2028-03-29 |
POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer |
60,234 | $0 | 60,234 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 4:56 pm |
N/A 2028-03-29 |
POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer |
381,795 | $0 | 381,795 (Direct) |
View |
Ownership(A) |
2022-03-17 7:20 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman 10% Owner |
0 | $0 | 538,087 (Indirect) |
View |
| 2021-06-30 Ownership |
2022-02-14 6:52 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Director 10% Owner |
23,309 | $0 | 8,864,091 (Indirect) |
View |
Ownership |
2022-02-14 6:52 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Director 10% Owner |
0 | $0 | 8,864,091 (Direct) |
View |
| 2021-06-30 Ownership |
2022-02-14 6:52 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Director 10% Owner |
313,884 | $0 | 8,864,091 (Indirect) |
View |
| 2021-06-30 Option Award(A) |
2022-02-08 2:25 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director |
35,872 | $0 | 35,872 (Indirect) |
View |
| 2021-12-09 Option Award |
2021-12-10 11:27 am |
N/A 2027-12-09 |
POINT Biopharma Global Inc. | PNT | KELLY JUSTYNA Chief Operating Officer |
70,000 | $0 | 70,000 (Direct) |
View |
Ownership |
2021-12-10 11:27 am |
N/A 2026-11-03 |
POINT Biopharma Global Inc. | PNT | KELLY JUSTYNA Chief Operating Officer |
0 | $0 | 31,836 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:40 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:39 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | Malik Rajesh Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:38 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | Lubner David Charles Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:37 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development |
461,250 | $0 | 461,250 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:37 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | GILMOUR MARGARET E. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:36 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | DEMERS WILLIAM L. Chief Financial Officer |
16,767 | $0 | 16,767 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:35 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:34 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:34 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | GOTTLIEB MICHAEL M. Chief Commercial Officer |
48,000 | $0 | 48,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:33 pm |
N/A 2027-07-06 |
POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:31 pm |
N/A 2026-03-25 |
POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Director |
8,870,878 | $0 | 4,297,136 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:30 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer |
3,614,153 | $0 | 3,614,153 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:30 pm |
N/A 2026-07-20 |
POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development |
125,553 | $0 | 125,553 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:29 pm |
N/A 2026-12-01 |
POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director |
35,872 | $0 | 35,872 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:29 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | GOTTLIEB MICHAEL M. Chief Commercial Officer |
1,156,887 | $0 | 1,156,887 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:28 pm |
N/A 2026-12-01 |
POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director |
57,395 | $0 | 93,267 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:27 pm |
N/A 2026-12-01 |
POINT Biopharma Global Inc. | PNT | GILMOUR MARGARET E. Director |
35,872 | $0 | 35,872 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:27 pm |
N/A N/A |
POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer |
3,820,778 | $0 | 3,587,607 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 9:26 pm |
N/A 2026-08-17 |
POINT Biopharma Global Inc. | PNT | DEMERS WILLIAM L. Chief Financial Officer |
179,362 | $0 | 179,362 (Direct) |
View |